US20040015206A1 - Percutaneous electrical therapy system with sharp point protection - Google Patents

Percutaneous electrical therapy system with sharp point protection Download PDF

Info

Publication number
US20040015206A1
US20040015206A1 US10/306,910 US30691002A US2004015206A1 US 20040015206 A1 US20040015206 A1 US 20040015206A1 US 30691002 A US30691002 A US 30691002A US 2004015206 A1 US2004015206 A1 US 2004015206A1
Authority
US
United States
Prior art keywords
electrode
housing
sharp point
patient
system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/306,910
Inventor
Jon Bishay
Paul Leonard
Kent Leyde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meagan Medical Inc
Original Assignee
Meagan Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/451,547 priority Critical patent/US6539264B1/en
Application filed by Meagan Medical Inc filed Critical Meagan Medical Inc
Priority to US10/306,910 priority patent/US20040015206A1/en
Assigned to MEAGAN MEDICAL, INC. reassignment MEAGAN MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VERTIS NEUROSCIENCE, INC.
Publication of US20040015206A1 publication Critical patent/US20040015206A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0502Skin piercing electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings

Abstract

The invention is a percutaneous electrical therapy system with sharp point protection. In a preferred embodiment, the system includes a control unit; an electrode assembly adapted to deliver electrical therapy to a patient, where the electrode assembly has an electrode electrically connectable to the control unit, the electrode having a sharp point at a distal end adapted to be inserted into the patient's tissue; and a sharp point protection assembly operable with the electrode assembly for reducing risk of unintended exposure to the electrode's point. The invention also includes an electrode assembly and sharp point protection assembly for a percutaneous electrical therapy system as described above, apart from the control unit.
The invention is also a method of performing percutaneous electrical therapy, the method including the steps of providing an electrode assembly having an electrode, the electrode having a sharp point at a distal end; inserting the sharp point of the electrode into a patient's tissue without exposing the sharp point to anyone but the patient; and applying an electrical signal to the electrode from a control unit.

Description

    BACKGROUND OF THE INVENTION
  • This invention relates generally to percutaneous electrical therapy systems for medical use, such as for pain treatment. In particular, the invention relates to a percutaneous electrical therapy system providing sharp point protection. [0001]
  • Electrical therapy has long been used in medicine to treat pain and other conditions. For example, transcutaneous electrical nerve stimulation (TENS) systems deliver electrical energy through electrode patches placed on the surface of a patient's skin to treat pain in tissue beneath and around the location of the patches. The efficacy of TENS systems in alleviating pain is questionable at best, however. [0002]
  • More recently, a technique in which electrodes are placed through the patient's skin into the target tissue has been proposed. Percutaneous Neuromodulation Therapy (“PNT”) (also sometimes called Percutaneous Electrical Nerve Stimulation or “PENS”) using percutaneously placed electrodes achieves significantly better pain relief results than TENS treatments using skin surface electrodes. This therapy is described in Ghoname et al., “Percutaneous Electrical Nerve Stimulation for Low Back Pain,” JAMA 281:818-23 (1999); Ghoname et al., “The Effect of Stimulus Frequency on the Analgesic Response to Percutaneous Electrical Nerve Stimulation in Patients with Chronic Low Back Pain,” Anesth. Analg. 88:841-6 (1999); Ahmed et al., “Percutaneous Electrical Nerve Stimulation (PENS): A Complementary Therapy for the Management of Pain Secondary to Bony Metastasis,” Clinical Journal of Pain 14:320-3 (1998); and Ahmed et al, “Percutaneous Electrical Nerve Stimulation: An Alternative to Antiviral Drugs for Herpes Zoster,” Anesth. Analg. 87:911-4 (1998). The contents of these references are incorporated herein by reference. [0003]
  • Thus far, PNT practitioners have used percutaneously placed acupuncture needles attached to waveform generators via cables and alligator clips to deliver the therapy to the patient. This arrangement and design of electrodes and generator is far from optimal. For example, the prior art has not addressed the issue of sharps protection for the patients' caregivers and other bystanders. It is therefore an object of this invention to reduce the exposure of electrical therapy patients' caregivers to accidental exposure to bloodborne pathogens, microbes, toxins, etc., via an injury caused by unintended contact with a sharp electrode. [0004]
  • It is a further object of this invention to provide a percutaneous electrical therapy system having electrodes and electrode assemblies that are safe, efficacious, inexpensive and easy to use. [0005]
  • Other objects of the invention will be apparent from the description of the preferred embodiments. [0006]
  • SUMMARY OF THE INVENTION
  • The invention is a percutaneous electrical therapy system with sharp point protection. In a preferred embodiment, the system includes a control unit; an electrode assembly adapted to deliver electrical therapy to a patient, where the electrode assembly has an electrode electrically connectable to the control unit, the electrode having a sharp point at a distal end adapted to be inserted into the patient's tissue; and a sharp point protection assembly operable with the electrode assembly for reducing risk of unintended exposure to the electrode's point. In some embodiments, the sharp point protection assembly includes a housing to contain at least the sharp point of the electrode when the electrode is in an undeployed state. In some of these embodiments, the sharp point of the electrode may be outside of the housing in a deployed state, the housing being adapted to contain a portion of the electrode in the deployed state. The housing may also be adapted to contain at least the sharp point of the electrode after the electrode has changed from the deployed state to an undeployed state. [0007]
  • In some embodiments, the sharp point protection assembly further has a locking assembly preventing relative movement between the electrode and the housing. The locking assembly may be a spring-biased detent. The system may also include a tool adapted to release the locking assembly and to move the sharp point of the electrode out of the housing. The tool may be further adapted to move the sharp point of the electrode back into the housing after having moved the sharp point of the electrode out of the housing and to engage the locking assembly to prevent further relative movement between the electrode and the housing. [0008]
  • In some embodiments the electrode assembly has an actuator attached to a proximal end of the electrode, the actuator being disposed within and movable within the housing. The system may also include an actuator tool adapted to interact with the actuator to move the sharp point of the electrode out of the housing. The actuator tool may be further adapted to move the sharp point of the electrode back into the housing after having moved the sharp point of the electrode out of the housing. The actuator tool may also have an electrical contact adapted to make electrical communication between the electrode and the control unit. [0009]
  • In some embodiments, the housing is adapted to contain none of the electrode when the electrode is in a deployed state in which the sharp point of the electrode has been inserted into the patient's tissue. The housing may be adapted to contain a plurality of electrodes. The system may also include an actuator adapted to move the electrode out of the housing. The housing may be adapted to contain a plurality of electrodes, the actuator being further adapted to move each electrode out of the housing one at a time. [0010]
  • The electrode assembly further may also include a patch adapted to be placed on the patient's skin and to support the electrode in the deployed state. The patch may have an opening adapted to surround a portion of the electrode when the electrode is in the deployed state. The patch may also include an annular member disposed in the patch opening and adapted to engage a handle portion of the electrode. The annular member may have a raised portion disposed above the patch and adapted to engage an aperture of the housing. [0011]
  • The system may also include an electrical connector attachable to the electrode handle portion to make electrical communication between the electrode and the control unit. [0012]
  • In some embodiments, the housing is a first housing, with the sharp point protection assembly further including a second housing to contain at least the sharp point of the electrode when the electrode has moved from the deployed state to an undeployed state. The system may also include an actuator adapted to move the electrode into the second housing. The system may also include an electrode grasper adapted to grasp the electrode in response to movement of the actuator, such as a fork adapted to mate with a handle portion of the electrode. The second housing may also be adapted to contain at least the sharp points of a plurality of electrodes, with the actuator being optionally further adapted to move a plurality of electrodes into the second housing. [0013]
  • In some embodiments, the sharp point protection assembly includes an aperture in the housing adapted to permit the electrode to pass through for deployment of the electrode. [0014]
  • In some embodiments, the system further comprises a movable actuator adapted to move the sharp point of the electrode into the patient's tissue. The system may also include an actuator limit element limiting movement of the actuator and controlling depth of insertion of the sharp point of the electrode into the patient's tissue. [0015]
  • In some embodiments, the system may also include an electrode insertion depth control mechanism. [0016]
  • In some embodiments, the system may also include a deployed electrode holding mechanism adapted to hold the electrode in place after insertion of the sharp point of the electrode into the patient's tissue. [0017]
  • In some embodiments, the system may also include an electrode insertion axial stabilizer adapted to provide axial stability to the electrode during insertion of the sharp point of the electrode into the patient's tissue. [0018]
  • In some embodiments, the system may also include an electrode insertion pain reducer adapted to reduce pain experienced by the patient during insertion of the sharp point of the electrode into the patient's tissue. [0019]
  • In some embodiments, the system may also include an electrode angle of entry controller adapted to control the electrode's entry angle during insertion of the sharp point of the electrode into the patient's tissue. [0020]
  • The invention is also a method of performing percutaneous electrical therapy, the method including the steps of providing an electrode assembly having an electrode, the electrode having a sharp point at a distal end; inserting the sharp point of the electrode into a patient's tissue without exposing the sharp point to anyone but the patient; and applying an electrical signal to the electrode from a control unit. The method may include the step of removing the electrode from the patient's tissue without exposing the sharp point to anyone but the patient. The method may also include the step of making an electrical connection between the electrode and the control unit. The method may also include the step of, after the inserting step, supporting the electrode in the patient's tissue. [0021]
  • In some embodiments, the inserting step includes the step of using the electrode assembly to guide electrode entry angle. In some embodiments, the inserting step includes the step of using an introducer to guide electrode entry angle. In some embodiments, the inserting step includes the step of providing axial stability to the electrode during insertion. In some embodiments, the inserting step includes the steps of placing a housing adjacent the patient's tissue; and moving the sharp point of the electrode out of the housing and into the patient's tissue. This method may also include the step of placing a patch on the patient's tissue prior to the step of placing a housing, in which the step of placing a housing includes the step of placing the housing adjacent the patch. In this method, the patch may have an opening, with the moving step including the step of moving the sharp point of the electrode out of the housing, through the opening and into the patient's tissue. The method may also include the step of mechanically supporting at least a portion of the electrode with the patch. [0022]
  • In some embodiments of the method, the moving step includes the steps of moving the entire electrode out of the housing; and removing the housing from the patient's tissue. In some embodiments, the housing is a first housing, the method further including the step of removing the electrode from the patient's tissue into a second housing without exposing the sharp point to anyone but the patient. [0023]
  • In some embodiments, the method includes the step of removing the electrode from the patient's tissue into the housing without exposing the sharp point to anyone but the patient. [0024]
  • The invention also includes an electrode assembly and sharp point protection assembly for a percutaneous electrical therapy system as described above, apart from the control unit. [0025]
  • The invention is described in further detail below with reference to the drawings.[0026]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. [0027] 1A-G are schematic renderings of a percutaneous electrical therapy system according to one embodiment of this invention.
  • FIG. 1A shows electrode and sharp point protection assemblies wherein the electrode is in an undeployed and uninserted state. [0028]
  • FIG. 1B shows the electrode and sharp point protection assemblies of FIG. 1A during deployment but prior to insertion of the electrode into a patient's tissue. [0029]
  • FIG. 1C shows the electrode and sharp point protection assemblies of FIG. 1A during deployment and insertion of the electrode into the patient's tissue. [0030]
  • FIG. 1D shows the electrode of FIG. 1A inserted into the patient's tissue. [0031]
  • FIG. 1E shows the electrode of FIG. 1A attached to a control unit to provide percutaneous electrical therapy. [0032]
  • FIG. 1F shows the electrode and sharp point protection assemblies of FIG. 1A during undeployment but prior to removing the sharp point of the electrode from the patient's tissue. [0033]
  • FIG. 1G shows the electrode and sharp point protection assemblies of FIG. 1A during undeployment and after removing the sharp point of the electrode from the patient's tissue. [0034]
  • FIGS. [0035] 2A-E are schematic renderings of a percutaneous electrical therapy system according to another embodiment of this invention.
  • FIG. 2A shows a percutaneous electrical therapy system with electrode and sharp point protection assemblies wherein the electrode is in an undeployed and uninserted state. [0036]
  • FIG. 2B shows the percutaneous electrical therapy system of FIG. 2A during deployment, but prior to insertion, of the electrode. [0037]
  • FIG. 2C shows the percutaneous electrical therapy system of FIG. 2A with the electrode in a deployed and inserted state. [0038]
  • FIG. 2D shows the percutaneous electrical therapy system of FIG. 2A during undeployment of the electrode. [0039]
  • FIG. 2E shows the percutaneous electrical therapy system of FIG. 2A after the electrode has been undeployed. [0040]
  • FIG. 3 shows an electrode montage for use in percutaneous neuromodulation therapy to treat low back pain. [0041]
  • FIG. 4 is an exploded sectional view of an electrode and sharp point protection assembly according to yet another embodiment of this invention. [0042]
  • FIG. 5 is a partially exploded elevational view of the embodiment of FIG. 4. [0043]
  • FIG. 6 is an elevational view of the embodiment of FIG. 4 showing the electrode and sharp point protection assemblies and an actuator tool. [0044]
  • FIG. 7 is a sectional view of the embodiment of FIG. 4 showing the electrode and sharp point protection assemblies and an actuator tool. [0045]
  • FIG. 8 is a sectional view of the embodiment of FIG. 4 showing the actuator tool in engagement with the electrode and sharp point protection assemblies prior to insertion of the electrode into a patient's tissue. [0046]
  • FIG. 9 is a sectional view of the embodiment of FIG. 4 with the electrode in its deployed and inserted state. [0047]
  • FIG. 10 shows a montage for using the embodiment of FIG. 4 to treat low back pain with the electrodes in a partially deployed but uninserted state. [0048]
  • FIG. 11 shows the electrode montage of FIG. 10 at the beginning of the electrode insertion step. [0049]
  • FIG. 12 shows the electrode montage of FIG. 10 with the electrodes deployed, inserted and attached to a control unit to provide electrical therapy to the patient. [0050]
  • FIG. 13 is an exploded view of an electrode introducer and sharp point protection assembly of yet another embodiment of this invention. [0051]
  • FIG. 14 is a partial sectional view of the introducer and sharp point protection assembly of FIG. 13. [0052]
  • FIG. 15 is a sectional view of the introducer and sharp point protection assembly of FIG. 13. [0053]
  • FIG. 16 is an elevational view of gear assemblies of the introducer and sharp point protection assembly of FIG. 13. [0054]
  • FIG. 17 shows part of the electrode assembly of the embodiment of FIGS. [0055] 13-16 in a montage used for treating low back pain using PNT.
  • FIG. 18 is an elevational view showing the introducer of FIG. 13 in the process of deploying an electrode. [0056]
  • FIG. 19 is a sectional view showing the introducer of FIG. 13 in the process of deploying an electrode, prior to insertion of the electrode. [0057]
  • FIG. 20 is a sectional view showing the introducer of FIG. 13 in the process of deploying an electrode, during insertion of the electrode. [0058]
  • FIG. 21 is a sectional view showing the introducer of FIG. 13 in the process of deploying an electrode, also during insertion of the electrode. [0059]
  • FIG. 22 is a sectional view of an inserted electrode assembly of the embodiment of FIGS. [0060] 13-16.
  • FIG. 23 is a partial sectional view of an electrode remover and sharp point protection assembly according to yet another embodiment of the invention prior to removal of an electrode. [0061]
  • FIG. 24 is a partial sectional view of the electrode remover and sharp point protection assembly of FIG. 23 partially actuated but prior to removal of an electrode. [0062]
  • FIG. 25 is a partial sectional view of the electrode remover and sharp point protection assembly of FIG. 23 partially actuated but prior to removal of an electrode. [0063]
  • FIG. 26 is a partial sectional view of the electrode remover and sharp point protection assembly of FIG. 23 partially actuated and engaged with an electrode but prior to removal of the electrode. [0064]
  • FIG. 27 is a partial sectional view of the electrode remover and sharp point protection assembly of FIG. 23 during removal of an electrode. [0065]
  • FIG. 28 is a partial sectional view of the electrode remover and sharp point protection assembly of FIG. 23 after removal of an electrode.[0066]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Percutaneous electrical therapy systems, such as PNT systems, deliver electric current to a region of a patient's tissue through electrodes that pierce the skin covering the tissue. The electric current is generated by a control unit external to the patient and typically has particular waveform characteristics such as frequency, amplitude and pulse width. Depending on the treatment or therapy being delivered, there may be one electrode containing both a cathode and an anode or a plurality of electrodes with at least one serving as a cathode and at least one serving as an anode. [0067]
  • The electrode has a sharp point to facilitate insertion through the patient's skin and to enhance local current density during treatment. Once inserted into the skin, the sharp point may become exposed to pathogens, microbes, toxins, etc. in the patient's tissue and/or blood. After removal of the electrode from the patient's tissue, a caregiver or other bystander may be stuck accidentally with the sharp point of the electrode, thereby exposing the caregiver to any pathogens that may be on the used electrode. This invention therefore provides a sharp point protection assembly for a percutaneous electrical therapy system. [0068]
  • FIGS. [0069] 1A-G are block diagrams showing deployment and use of one embodiment of this percutaneous electrical therapy system and electrode assembly invention. As shown in FIGS. 1A and 1B, the system includes an electrode 1 having a sharp point 2 at its distal end and a sharp point protection assembly 3 surrounding at least the electrode's sharp point 2 when the electrode is in its undeployed and uninserted states. The undeployed and uninserted states include pre-deployment and post-deployment states of the electrode. In this embodiment, sharp point protection assembly 3 includes a housing 4 having an aperture 5 at its distal end. An actuator 6 interacts with a handle 11 at the proximal end of electrode 2 as shown.
  • Deployment of the electrode assembly includes the steps taken to place the electrode assembly in proper position and condition for use in electrical therapy. FIG. 1A shows the electrode assembly in an undeployed (pre-deployed) state. During deployment, aperture [0070] 5 is placed against a patient's skin 22, as shown in FIG. 1B. Electrode 2 is then inserted into the tissue underlying the patient's skin by moving actuator 6 distally, as shown in FIG. 1C. Actuator 6 may have an optional limit stop 9 element cooperating with a limit stop area 8 of housing 4 to limit distal motion of actuator 6 and to control the depth of insertion of sharp point 2 of electrode 1. In a preferred embodiment of the invention, for example, where the electrical therapy system is used to provide percutaneous neuromodulation therapy, the predetermined electrode depth is 3 cm. Other electrode depths may be used, of course, depending on the intended application and therapy.
  • After insertion, housing [0071] 4 and actuator 6 (which have heretofore acted as an electrode introducer) are preferably removed, as shown in FIG. 1D. Electrode 1 is connected to a control unit 10 via a conductor or cable 16. For use with PNT, control unit 10 preferably supplies a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec. Other electrical waveforms having other parameters may be used, of course, depending on the therapy to be provided. Also, while FIG. 1E shows only one electrode connected to the control unit, it should be understood that a plurality of electrodes may be connected to a single control unit, as called for by the desired electrical stimulation treatment.
  • After completion of the electrical therapy, the electrode assembly is undeployed. During undeployment, the electrode must be removed from the patient in a sharps-safe manner. In this embodiment, as shown in FIG. 1F, the aperture [0072] 5 of the housing 4 of a sharp point protection assembly 3 is placed over the handle portion 11 of electrode 1. Sharp point protection assembly 3 may be the same assembly used to deploy and insert the electrode (i.e., the electrode introducer), or it may be an entirely different assembly (e.g., an electrode remover). The sharp point 2 of electrode 1 is then drawn into housing 4 of sharp point protection assembly 3 by moving actuator 6 proximally, as shown in FIG. 1G. Thus, sharp point protection assembly 3 of FIGS. 1A-G helps prevent all unintended contact between the electrode's sharp point and a caregiver or other bystander before, during and after deployment of the electrode.
  • FIGS. [0073] 2A-E are block diagrams of another embodiment of our percutaneous electrical therapy system and electrode assembly invention. A control unit 10 is connected to an electrode 12 within an electrode assembly 13 via a conductor 16. As above, for use with PNT, control unit 10 preferably supplies a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec. As shown in its undeployed state in FIG. 2A and in its uninserted stated in FIG. 2B, the system includes a sharp point protection assembly 14 comprising a housing 18 surrounding the sharp point 20 of electrode 12 when the electrode point 20 has not yet been inserted through the patient's skin 22.
  • To begin deployment, distal face [0074] 21 of housing 18 is place against the patient's skin 22, as shown in FIG. 2B. The system may also include an electrode actuator 19 that enables deployment and insertion of the sharp point 20 of electrode 12 through the patient's skin 22 into the underlying tissue to a predetermined depth through an aperture 24 in housing 18, as shown in FIG. 2C. Actuator 19 may be part of the electrode assembly 13 or a separate component of the system. Actuator may have an optional limit stop element 23 that cooperates with a limit stop area 17 of housing 18 to limit distal movement of actuator 19, thereby controlling depth of insertion of electrode 12. In a preferred embodiment of the invention, for example, where the electrical stimulation system is used to provide percutaneous neuromodulation therapy, the predetermined electrode depth is approximately 3 cm., although other electrode depths may be used depending on the application. The control unit 10 may then provide the appropriate therapy to the patient through electrode 12 and any other electrodes connected to it.
  • During undeployment, actuator [0075] 19 is used to draw electrode 12 back proximally into housing 18. After removal of the electrode from the patient's skin, housing 18 of sharp point protection assembly 14 once again surrounds the sharp point 20 of the now uninserted electrode 12, as shown in FIGS. 2D and 2E. Actuator 19 helps enable this operation to occur without ever exposing the sharp point of the electrode when the sharp point is no longer in the patient. In fact, the operator of the electrode assembly never sees the sharp point of the electrode. Thus, sharp point protection assembly 14 shields the potentially contaminated portion of the undeployed electrode and protects the patient's caregiver or other bystander from unintended contact with the sharp point of the electrode before, during and after electrical therapy.
  • While FIGS. [0076] 2A-E show the electrode connected to the control unit prior to deployment and insertion of the electrode into the patient's skin, the connection between the control unit and the electrode could be made during deployment or after insertion. Also, while FIGS. 2A-E show only one electrode connected to the control unit, it should be understood that a plurality of electrodes may be connected to a single control unit, as called for by the desired electrical stimulation treatment.
  • To use the percutaneous electrical therapy systems of FIGS. [0077] 1A-G and FIGS. 2A-E to treat a patient, one or more electrodes are inserted through the patient's skin into the underlying tissue. As an example, to treat low back pain using PNT with unipolar electrodes, an array or montage such as that shown in FIG. 3 may be used. The “T12”-“S1” designations refer to the patient's vertebrae. The sharp point protection assembly shields the electrode assembly operator from exposure to the electrode's sharp point prior to, during and after treatment. The control unit or generator supplies current pulses between pairs of electrodes for durations of a few minutes to several hours, preferably delivering the current-regulated waveform described above. Thirty minute treatments are recommended in the Ghoname et al. low back pain treatment articles.
  • During deployment and treatment, the electrode assembly and other parts of the system perform other functions in addition to being a sharps-protected conduit for current flow into the patient. For example, in the embodiment of FIGS. [0078] 2A-E, aperture 24, distal face 21 and the interaction of actuator 19 and housing 18 cooperate as an electrode angle of entry controller to control the electrode's entry angle during insertion of the sharp point of the electrode into the patient's tissue. The interaction of aperture 5, distal face 7 of housing 4, and the interaction of actuator 6 and housing 4 perform this function in the embodiment of FIGS. 1A-G.
  • Additional optional details of the electrode assembly may be found in the following concurrently filed and commonly owned U.S. patent applications, the disclosures of which are incorporated herein by reference: Bishay et al., “Percutaneous Electrical Therapy System With Electrode Entry Angle Control;” Leonard et al., “Percutaneous Electrical Therapy System Providing Electrode Axial Support;” Leonard et al, “Percutaneous Electrical Therapy System With Electrode Depth Control;” Leonard et al., “Percutaneous Electrical Therapy System With Electrode Position Maintenance;” Leonard et al., “Electrode Introducer For A Percutaneous Electrical Therapy System;” Bishay et al, “Percutaneous Electrical Therapy System For Minimizing Electrode Insertion Discomfort;” Bishay et al., “Electrode Assembly For A Percutaneous Electrical Therapy System;” and Leonard et al., “Electrode Remover For A Percutaneous Electrical Therapy System.”[0079]
  • FIGS. [0080] 4-12 show another embodiment of this invention. An electrode assembly 30 includes a base 32, an electrode 34, and a plunger or actuator 36. Base 32 has a flange or flared end 44 that is adapted to make contact with a patient's skin. Base 32 may be formed from any suitable polymer or metal, such as a high density polyethylene (HDPE). Base 32 is preferably opaque so that the electrode cannot be seen by a needle-shy patient.
  • Actuator [0081] 36 fits within a housing portion 40 of base 32 in a slidable arrangement. A locking assembly is operable to prevent relative movement between actuator 36 and housing 40 of base 32. In this embodiment, the locking assembly of actuator 36 has integrally-formed resilient detents 48 on its exterior cylindrical surface. In the undeployed state of electrode assembly 30, detents 48 mate with a corresponding openings 50 in base 32 to hold actuator 36 and base 32 in place with respect to each other to prevent electrode 34 from moving outside of the protective housing 40 of base 32 and thereby providing sharp point protection, as explained further below. Mechanisms other than the detent and opening arrangement shown here may be used to hold the actuator and base in place may be used without departing from the invention.
  • In this embodiment, electrode [0082] 34 is preferably a 3 cm. long 32 gauge stainless steel needle. Other sizes and materials may be used for electrode 34, of course, without departing from the scope of the invention. Actuator 36 is preferably formed from HDPE as well, although other suitable materials may be used.
  • Electrode [0083] 34 has a larger-diameter handle 52 at its proximal end. Handle 52 fits within a channel 54 formed within actuator 36. Channel 54 has a narrow opening 56 at its distal end whose diameter is slightly larger than the diameter of electrode 34 but narrower than the diameter of handle 52 to hold electrode 34 in place within actuator 36 after initial manufacture and assembly. As shown in FIG. 7, in an undeployed state the sharp point 38 of electrode 34 is disposed within housing portion 40 of base 32, specifically, within a narrow channel 42 of the housing 40.
  • To deploy one or more electrode assemblies on a patient in order to provide electrical stimulation therapy (such as PNT), the distal surface [0084] 46 of flange portion 44 of base 32 is mounted on the desired site on the patient's skin, preferably with a compressible adhesive pad (not shown) surrounding a ring 43 extending downward from surface 46 around an aperture 41 formed at the distal end of channel 42, although other means of attaching base 32 to the patient may be used as appropriate.
  • An electrical connector and actuator tool [0085] 60 is used to insert the electrode and connect the electrode electrically with a control unit 62. Actuator tool 60 and electrode assembly 30 also interact to provide the sharp point protection assembly of this embodiment. When the distal end of actuator tool 60 is placed against the proximal ends of base 32 and actuator 36, the exposed proximal end 64 of electrode handle 52 makes electrical contact with a contact surface 66 within actuator tool 60. Contact surface 66, in turn, is electrically connected to the control unit 62 via a cable or other conductor 68.
  • Actuator tool [0086] 60 has two oppositely disposed pegs 70 extending outward from the distal portion of its cylindrically surface. Pegs 70 mate with two corresponding slots 72 in actuator 36 and with two corresponding grooves 74 in base 32. (The second slot 72 and second groove 74 are each opposite the slot 72 and groove 74, respectively, shown in FIGS. 4 and 5.) When connecting actuator tool 60 to electrode assembly 30, pegs 70 move along longitudinal portions 76 of slots 72 and along longitudinal portions 78 of grooves 74. Concurrently, exposed distal end 64 of electrode handle 52 begins to make sliding contact with contact surface 66 of actuator tool 60 to create the electrical connection between actuator tool 60 and electrode 32.
  • Clockwise rotation (looking down on the assembly) of actuator tool [0087] 60 after pegs 70 reach the end of longitudinal portions 76 and 78 moves pegs 70 into short circumferential portions 80 and 82, respectively, of slots 72 and grooves 74. The length of circumferential portions 80 of slots 72 is less than the length of circumferential portions 82 of grooves 74. Continued movement of pegs 70 along circumferential portions 82 will therefore move pegs 70 against the ends 81 of circumferential slots 80. Further clockwise rotation of actuator tool 60 will cause actuator 36 to rotate clockwise as well, thereby moving detents 48 out of openings 50 and allowing the electrode 34 and actuator 36 to move with respect to base 32.
  • Second longitudinal portions [0088] 84 of grooves 74 are formed in base 32 at the end of circumferential portions 82. Movement of pegs 70 distally along longitudinal portions 84 pushes pegs 70 against the distal edges of circumferential slot portions 80, thereby moving actuator 36 and electrode 34 distally toward the patient's skin 22.
  • As it moves, electrode [0089] 34 passes through channel 42, and the sharp point of electrode 34 moves out through aperture 41. Channel 42 and actuator 36 provide axial support to electrode 34 during this forward movement and also, along with the support provided by flange 44, provide entry angle guidance to the electrode. In addition, downward pressure on the patient's skin during electrode deployment compresses the compressible adhesive pad and presses ring 43 against the patient's skin 22, which helps ease electrode entry through the skin and also lessens the insertion pain experienced by the patient.
  • Distal movement of the electrode and its actuator within base [0090] 32 continues until the distal surface 86 of a cylindrical cap portion 92 of actuator tool 60 meets an annular surface 88 of housing 40. At this point, sharp point 38 of electrode 34 has extended a predetermined depth into the tissue underlying the patient's skin. In the preferred embodiment, this predetermined depth is approximately 3 cm., although other electrode depths may be desired depending on the treatment to be performed.
  • An optional feature of the invention is a deployed electrode holding mechanism. In this embodiment, an interference fit between the inner surface of channel [0091] 42 and the outer surface 55 of channel 52 performs this function.
  • Electrical stimulation treatment may begin once the electrodes have been deployed and inserted. Control unit [0092] 62 supplies stimulation current to the electrodes, e.g. in the manner described in the Ghoname et al. articles. The electrical waveform provided by the control unit depends on the application. For example, in an embodiment of a system providing percutaneous neuromodulation therapy, control unit 62 would preferably provide a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec.
  • The interaction of actuator tool [0093] 60 and base 32 provides stability to electrode 34 and its electrical connection to the control unit during treatment by holding the electrode in place, by providing strain relief for tugging forces on cable 68, and by providing a robust mechanical connection. It should be noted that the sharp point of the electrode is not exposed to the operator or to any other bystander at any point during deployment and use of the electrode assembly.
  • After treatment has been completed, the electrode may be removed from the patient. To do so, actuator tool [0094] 60 is moved proximally away from the patient. As pegs 70 move proximally along longitudinal portions 84 of grooves 74, pegs 70 push against proximal edges of the actuator's circumferential slot portions 80, thereby moving actuator 36 and electrode 34 proximally as well. When pegs reach the proximal end of longitudinal groove portions 84, the sharp end 38 of electrode 34 is out of the patient and safely inside housing 40 of base 32. Counterclockwise movement of actuator tool 60 moves pegs along circumferential portions 80 and 82 of slot 72 and groove 74, respectively. Since, as discussed above, circumferential portion 80 is shorter than circumferential portion 82, this counterclockwise movement will turn actuator 36 counterclockwise.
  • At the limit of the counterclockwise movement, detents [0095] 48 move back into openings 50 to prevent further movement of the electrode and actuator with respect to base 32. Further distal movement of actuator tool 60 moves pegs 70 distally along longitudinal portions 76 and 78 of slot 72 and groove 74, respectively, to disconnect actuator tool 60 from electrode assembly 30. Base 32 can then be removed from the patient.
  • Once again, at no time during the electrode deployment, use or removal processes was the sharp point of the electrode exposed to the operator or bystanders. [0096]
  • FIGS. [0097] 10-12 show the use of the electrode and sharp point protection assemblies of FIGS. 4-9 to treat low back pain using PNT. As shown in FIG. 10, ten electrode assemblies 30 a-j are arranged in a montage on the patient's back and attached with adhesive. Next, ten actuator tools 60 aj are attached to the ten electrode assemblies 30 a-j. In this example, prior to deployment the actuator tools are mounted on an actuator tool tray 61 that provides electrical communication to a control unit 62 via cable 69. The actuator tools electrically connect with tool tray 61, and thereby to cable 69 and control unit 62, via individual cables 68 aj. It should be understood that the tool tray 61 and its electrical connection scheme play no part in this invention. FIG. 11 shows the beginning of the electrode insertion process.
  • Once each electrode assembly has been actuated by its respective actuator tool to insert an electrode into the patient's tissue (as shown in FIG. 12), control unit [0098] 62 provides electrical signals to treat the patient. Preferably, half the electrodes (e.g., assemblies 30 b, 30 d, 30 g, 30 h and 30 i) are treated as anodes, and the other half as cathodes. In the preferred embodiment, control unit 62 would provide a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec. to treat the patient's low back pain using PNT.
  • Another embodiment of the invention is shown in FIGS. [0099] 13-28. In this embodiment, an electrode introducer and an electrode remover cooperate to provide sharp point protection.
  • A preferred embodiment of an electrode introducer [0100] 100 is shown in FIGS. 13-16 and 19-21. In this embodiment, introducer 100 is designed to insert multiple electrodes. It should be understood that the principles of this invention could be applied to an introducer designed to hold and insert any number of electrodes.
  • Twelve electrodes [0101] 102 are disposed within a magazine 103 rotatably mounted within a housing 104. In this embodiment, housing 104 is a two-part injection molded polystyrene assembly. As seen best in FIG. 14, magazine 103 rotates about a hub 105 mounted on supports formed in housing 104. A leaf spring 106 mates with one of twelve radial grooves 108 formed in magazine 103 to form a twelve-position ratchet mechanism for rotatable magazine 103 in housing 104.
  • Magazine [0102] 103 has twelve electrode chambers 115 arranged radially about hub 105. When introducer 100 is completely full, each chamber 115 contains one electrode 102. The diameter of upper portion 118 of chamber 115 is sized to form an interference fit with the wider portions 112 and 114 of electrode handle portion 107 of electrode 102. Lower wide portion 114 of electrode 102 is formed from a compressible material. The diameter of lower portion 119 of chamber 115 is slightly larger so that there is no interference fit between chamber portion 119 and electrode handle 107, for reasons explained below. Each time leaf spring 106 is within a groove 108, the opening 106 of a magazine chamber 115 is lined up with the aperture 117 of introducer 100, as shown in FIGS. 14 and 15.
  • A slide member [0103] 109 is disposed on a rail 110 formed in housing 104. Extending longitudinally downward from slide member 109 is a drive rod 111, and extending longitudinally upward from slide member 109 is a gear rack 120. The teeth of gear rack 120 cooperate with teeth on a rotational gear 122 mounted about a shaft 124 extending into a shaft mount 126 formed in housing 104. A second set of teeth are mounted on a smaller diameter rotational gear 128 (shown more clearly in FIG. 16) which is also mounted about shaft 124. Gears 122 and 128 rotate together about shaft 124.
  • The teeth of smaller diameter gear [0104] 128 mesh with the teeth of a second gear rack 130 extending from a longitudinally-movable actuator 132. A spring 134 mounted between actuator 132 and a spring platform 136 biases actuator 132 away from housing 104.
  • To deploy the electrode assembly of this embodiment, a flexible and compressible annular patch [0105] 140 is placed on the patient's skin at the desired site, preferably with adhesive (not shown). For example, to treat low back pain using PNT, the arrangement or montage shown in FIG. 17 may be used. In this montage, five electrodes serve as cathodes and five serve as anodes.
  • As shown in FIGS. 19 and 20, patch [0106] 140 has an annular rigid member 141 disposed in its center and extending upwardly from it. Rigid member 141 has a smaller diameter opening 142 leading to a larger diameter opening 144. The diameter of opening 142 is slightly smaller than the lower wide portion 114 of the handle portion 107 of electrode 102 and slightly larger than the diameter of the central portion 113 of handle portion 107 of electrode 102.
  • After the patch [0107] 140 is in place, the distal end of introducer 100 is placed against patch 140 so that introducer aperture 117 surrounds the upwardly extending portion of rigid patch member 141, as shown in FIG. 18. This interaction aligns the opening 116 of one of the introducer's magazine chambers 115 with the opening 142 of rigid member 141 and helps control the electrode's angle of entry, as shown in FIG. 19. Downward pressure on introducer 100 compresses patch 140, thereby causing the upper surface of rigid member 141 to engage a lower surface of magazine 103 and pressing rigid member 141 downward into the patient's skin 22. This pressure on the patient's skin around the insertion site minimizes the pain of insertion of the electrode.
  • Depressing actuator [0108] 132 moves gear rack 130 distally, which causes gears 128 and 122 to rotate. Because of the relative diameters and relative tooth counts of gears 128 and 122, gear rack 120 moves longitudinally a much greater distance than the corresponding longitudinal movement of gear rack 130. This feature enables the electrode to be inserted its required distance into the patient's skin using only a comparatively small movement of the operator's thumb. Distal movement of gear rack 120 is guided by the movement of slide member 109 along rail 110.
  • As slide member [0109] 109 moves distally, drive rod 111 moves into a magazine chamber 115 until the distal end of drive rod 111 engages the top surface of the electrode's handle portion 107. As shown in FIG. 20, further distal movement of drive rod 111 pushes electrode 102 downward so that sharp point 108 of electrode 102 leaves the introducer housing and enters the patient's skin 22 and the tissue beneath the skin. Chamber 115 provides axial stability to the electrode 102 during insertion.
  • When the top portion [0110] 112 of electrode handle portion 107 leaves the smaller diameter portion 118 of magazine chamber 115, it enters the larger diameter portion 119 of chamber 115. At this point (shown in FIG. 21), because the diameter of chamber portion 119 is wider than the diameter of the electrode handle 107, the electrode is no longer attached to introducer 100.
  • Continued downward movement of actuator [0111] 132 and drive rod 111 pushes the lower larger diameter portion 114 of electrode handle 107 through the smaller diameter portion 142 of rigid member 141 by compressing handle portion 114. Further downward movement pushes handle portion 114 into the larger diameter portion 144 of rigid member 141 so that the rigid member's smaller diameter portion lies between the larger diameter portions 112 and 114 of the electrode handle 107. This interaction holds the electrode in place in the patient's tissue and helps provides depth control for electrode insertion. In this embodiment, the preferred depth of the electrode's sharp point 108 is approximately 3 cm., although other electrode depths may be desired depending on the treatment to be performed. Slider member 109 also acts as a limit stop at this point when it engages the limit stop area 145 of housing 104, thereby also controlling electrode insertion depth.
  • Magazine [0112] 103 is rotated to a new insertion position and placed against an empty patch 140 after insertion of each electrode until all electrodes have been deployed and inserted. A suitable electrical connector 148 such as an alligator clip is electrically connected to electrode 102 through an aperture (not shown) formed in the upper larger diameter portion 112 of electrode handle 107 to provide electrical communication between a control unit 150 and electrode 102 via a cable or other conductor 149, as shown in FIG. 22. Patch 140 provides strain relief for electrode 102 by preventing tugging forces on cable 149 from dislodging the electrode from the patient, thereby helping keep the electrode in place.
  • Control unit [0113] 150 supplies stimulation current to the electrodes, e.g., in the manner described in the Ghoname et al. articles. Once again, the electrical waveform provided by the control unit depends on the application. For example, in an embodiment of a system providing percutaneous neuromodulation therapy, control unit 150 would preferably provide a current-regulated and current-balanced waveform with an amplitude of up to approximately 20 mA, frequency between approximately 4 Hz and 50 Hz, and pulse width of between approximately 50 μsec and 1 msec.
  • It should be noted that at no time during the electrode deployment, insertion and electrical therapy treatment processes was the sharp point of the electrode exposed to the operator or bystanders. [0114]
  • In an alternative embodiment, the lower wide portion of the electrode handle is formed from a rigid material and has rounded camming edges. The central annulus of patch [0115] 140 in this alternative embodiment is either compressible or has a resilient camming opening under the camming action of the electrode handle.
  • FIGS. [0116] 23-28 show a sharps-safe remover according to one embodiment of this invention. Remover 200 is designed to work with the electrode and electrode patch assembly described with respect to FIGS. 13-22 above. It should be understood that the principles of sharps-safe remover 200 may apply to other electrode designs as well.
  • Remover [0117] 200 has a housing 202 with an aperture 204 at its distal end. A number of previously undeployed electrodes 102 are stored within housing 202. A pair of rails 214 and 216 hold the electrodes 102 in alignment via the electrode handles 107, as shown. While this embodiment of the remover is designed to provide sharps-safe removal and storage of a plurality of electrodes, the invention applies to removers designed to remove and store one or any number of electrodes.
  • As described above, electrodes for percutaneous electrical therapy are inserted through a patient's skin into underlying tissue with handle portions exposed above the skin. The first step in undeploying and removing an inserted electrode is to line up the exposed handle [0118] 107 of an electrode with the remover's aperture 204, as shown in FIG. 23, by placing the distal face 205 of remover 200 against the patient's skin or against any portion of the electrode assembly (such as an adhesive patch) surrounding the electrode. While not shown in FIGS. 23-28, aperture 204 is sized to surround an annular member (such as annular member 141 discussed above) holding an electrode handle of an electrode assembly (such as that shown in FIGS. 13-22 above), the sharp point of which has been inserted through a patient's skin.
  • An electrode engagement fork [0119] 206 is pivotably attached to a longitudinally movable actuator 208 via an arm 209 and a hinged pivot 210. A coil spring 212 biases actuator 208 upwards towards the actuator and fork position shown in FIG. 28. A leaf spring 218 extends from arm 209. A cross-bar 220 at the end of leaf spring 218 slides in groove 222 and a corresponding groove (not shown) on the other side of housing 202. Leaf spring 218 is in its relaxed state in the position shown in FIG. 23. In this position, a cross-bar 224 extending from the distal end of arm 209 adjacent fork 206 lies at the top of a camming member 226 and a corresponding camming member (not shown) on the other side of housing 202.
  • Downward movement of actuator [0120] 208 (in response, e.g., to pressure from a user's thumb) against the upward force of spring 212 moves cross-bar 224 against a first camming surface 228 of camming member 226, as shown in FIG. 24. Camming surface 228 pushes cross-bar 224 of arm 209 against the action of leaf spring 218 as actuator 208, arm 209 and fork 206 move downward.
  • FIG. 25 shows the limit of the downward movement of fork [0121] 206. At this point, crossbar 224 clears the camming member 226, and leaf spring 218 rotates fork 206 and arm 209 about pivot 210 to engage fork 206 with electrode handle 107, as shown in FIG. 26. The tine spacing of fork 206 is shorter than the diameter of the upper wide portion 112 of electrode handle 107 but wider than the diameter of the narrow middle portion 113 of electrode handle 107.
  • Release of actuator [0122] 208 by the user permits spring 212 to move actuator 208, arm 209 and fork 206 proximally. The engagement between fork 206 and electrode handle 107 causes the electrode to begin to move proximally with the fork out of the patient and into the remover housing, as shown in FIG. 27. At this point, cross-bar 224 is now engaged with a second camming surface 230 of camming member 226. Camming surface 230 pushes cross-bar 224 against the action of leaf spring 218 in the other direction (to the left in the view shown in FIG. 27) as the electrode, fork and arm rise under the action of coil spring 212.
  • The electrode and fork continue to rise until they reach the upward limit of their permitted motion, as shown in FIG. 28. At this point, electrode handle [0123] 107 has engaged rails 214 and 216 and the most recent electrode previously stored in remover 200. Electrode handle 107 pushes against the electrode handle of the previously stored electrode handle, which in turn pushes against any electrode handles stored above it in the stack. In this manner, the latest electrode removed by remover 200 goes into the bottom of the stack of used electrodes stored in remover 200. Now that the sharp point 108 of electrode 102 is safely inside housing 202, remover 200 can be withdrawn from the site on the patient's skin through which the electrode had been inserted. Once cross-bar 224 clears the top of camming member 226, and leaf spring 218 moves arm 209 back to the center position shown in FIG. 23.
  • It should be noted that remover [0124] 200 provides sharp point protection for the entire electrode undeployment and removal process. Once all electrodes have been removed, the used electrodes can be safely transported in the sharps-safe container provided by the housing 202 of remover 200.
  • Modifications of the above embodiments of the invention will be apparent to those skilled in the art. For example, while the invention was described in the context of percutaneous electrical therapy in which electrodes are used to deliver electricity to a patient, the sharps-safe features may be used with electrodes designed for medical monitoring and/or diagnosis. In addition, the sharps-safe features of this invention may be used with acupuncture needles or other needles not used for conducting electricity to or from a patient. [0125]

Claims (51)

What is claimed is:
1. A percutaneous electrical therapy system comprising:
a control unit;
an electrode assembly adapted to deliver electrical therapy to a patient, the electrode assembly comprising an electrode electrically connectable to the control unit, the electrode comprising a sharp point at a distal end adapted to be inserted into the patient's tissue; and
a sharp point protection assembly operable with the electrode assembly for reducing risk of unintended exposure to the electrode's point.
2. The system of claim 1 wherein the sharp point protection assembly comprises a housing to contain at least the sharp point of the electrode when the electrode is in an undeployed state.
3. The system of claim 2 wherein the sharp point of the electrode is outside of the housing in a deployed state, the housing being adapted to contain a portion of the electrode in the deployed state.
4. The system of claim 3 wherein the housing is adapted to contain at least the sharp point of the electrode after the electrode has changed from the deployed state to an undeployed state.
5. The system of claim 2 wherein the sharp point protection assembly further comprises a locking assembly preventing relative movement between the electrode and the housing.
6. The system of claim 5 wherein the locking assembly comprises a spring-biased detent.
7. The system of clam 5 further comprising a tool adapted to release the locking assembly and to move the sharp point of the electrode out of the housing.
8. The system of claim 7 wherein the tool is further adapted to move the sharp point of the electrode back into the housing after having moved the sharp point of the electrode out of the housing and to engage the locking assembly to prevent further relative movement between the electrode and the housing.
9. The system of claim 2 wherein the electrode assembly further comprises an actuator attached to a proximal end of the electrode, the actuator being disposed within and movable within the housing.
10. The system of claim 9 further comprising an actuator tool adapted to interact with the actuator to move the sharp point of the electrode out of the housing.
11. The system of claim 10 wherein the actuator tool is further adapted to move the sharp point of the electrode back into the housing after having moved the sharp point of the electrode out of the housing.
12. The system of claim 11 wherein the actuator tool has an electrical contact adapted to make electrical communication between the electrode and the control unit.
13. The system of claim 10 further comprising a locking assembly preventing relative movement between the actuator and the housing, the actuator tool being adapted to release the locking mechanism and to move the sharp point of the electrode out of the housing.
14. The system of claim 2 wherein the housing is adapted to contain none of the electrode when the electrode is in a deployed state in which the sharp point of the electrode has been inserted into the patient's tissue.
15. The system of claim 14 wherein the housing is adapted to contain a plurality of electrodes.
16. The system of claim 14 further comprising an actuator adapted to move the electrode out of the housing.
17. The system of claim 16 wherein the housing is adapted to contain a plurality of electrodes, the actuator being further adapted to move each electrode out of the housing one at a time.
18. The system of claim 14 wherein the electrode assembly further comprises a patch adapted to be placed on the patient's skin and to support the electrode in the deployed state.
19. The system of claim 18 wherein the patch has an opening adapted to surround a portion of the electrode when the electrode is in the deployed state.
20. The system of claim 19 wherein the patch further comprises an annular member disposed in the patch opening and adapted to engage a handle portion of the electrode.
21. The system of claim 20 wherein the annular member comprises a raised portion disposed above the patch and adapted to engage an aperture of the housing.
22. The system of claim 14 further comprising an electrical connector attachable to the electrode handle portion to make electrical communication between the electrode and the control unit.
23. The system of claim 14 wherein the housing is a first housing, the sharp point protection assembly further comprising a second housing to contain at least the sharp point of the electrode when the electrode has moved from the deployed state to an undeployed state.
24. The system of claim 23 further comprising an actuator adapted to move the electrode into the second housing.
25. The system of claim 24 further comprising an electrode grasper adapted to grasp the electrode in response to movement of the actuator.
26. The system of claim 25 wherein the electrode grasper is a fork adapted to mate with a handle portion of the electrode.
27. The system of claim 23 wherein the second housing is adapted to contain at least the sharp points of a plurality of electrodes.
28. The system of claim 27 further comprising an actuator adapted to move a plurality of electrodes into the second housing.
29. The system of claim 2 wherein the sharp point protection assembly further comprises an aperture in the housing adapted to permit the electrode to pass through for deployment of the electrode.
30. The system of claim 1 further comprising a movable actuator adapted to move the sharp point of the electrode into the patient's tissue.
31. The system of claim 30 further comprising an actuator limit element limiting movement of the actuator and controlling depth of insertion of the sharp point of the electrode into the patient's tissue.
32. The system of claim 1 wherein the electrode assembly further comprises an electrode insertion depth control mechanism.
33. The system of claim 1 wherein the electrode assembly further comprises a deployed electrode holding mechanism adapted to hold the electrode in place after insertion of the sharp point of the electrode into the patient's tissue.
34. The system of claim 1 further comprising an electrode insertion axial stabilizer adapted to provide axial stability to the electrode during insertion of the sharp point of the electrode into the patient's tissue.
35. The system of claim 1 further comprising an electrode insertion pain reducer adapted to reduce pain experienced by the patient during insertion of the sharp point of the electrode into the patient's tissue.
36. The system of claim 1 further comprising an electrode angle of entry controller adapted to control the electrode's entry angle during insertion of the sharp point of the electrode into the patient's tissue.
37. A method of performing percutaneous electrical therapy comprising:
providing an electrode assembly comprising an electrode, the electrode comprising a sharp point at a distal end;
inserting the sharp point of the electrode into a patient's tissue without exposing the sharp point to anyone but the patient; and
applying an electrical signal to the electrode from a control unit.
38. The method of claim 37 further comprising:
removing the electrode from the patient's tissue without exposing the sharp point to anyone but the patient.
39. The method of claim 37 further comprising:
making an electrical connection between the electrode and the control unit.
40. The method of claim 37 further comprising after the inserting step:
supporting the electrode in the patient's tissue.
41. The method of claim 37 wherein the inserting step comprises:
using the electrode assembly to guide electrode entry angle.
42. The method of claim 37 wherein the inserting step comprises:
using an introducer to guide electrode entry angle.
43. The method of claim 37 wherein the inserting step comprises:
providing axial stability to the electrode during insertion.
44. The method of claim 37 wherein the inserting step comprises:
placing a housing adjacent the patient's tissue; and
moving the sharp point of the electrode out of the housing and into the patient's tissue.
45. The method of claim 44 further comprising placing a patch on the patient's tissue prior to the step of placing a housing, the step of placing a housing comprising placing the housing adjacent the patch.
46. The method of claim 45 wherein the patch comprises an opening, the moving step comprising moving the sharp point of the electrode out of the housing, through the opening and into the patient's tissue.
47. The method of claim 45 further comprising:
mechanically supporting at least a portion of the electrode with the patch.
48. The method of claim 44 wherein the moving step comprises:
moving the entire electrode out of the housing; and
removing the housing from the patient's tissue.
49. The method of claim 48 wherein the housing comprises a first housing, the method further comprising:
removing the electrode from the patient's tissue into a second housing without exposing the sharp point to anyone but the patient.
50. The method of claim 44 further comprising removing the electrode from the patient's tissue into the housing without exposing the sharp point to anyone but the patient.
51. An electrode assembly and sharp point protection assembly for a percutaneous electrical therapy system comprising:
an electrode assembly adapted to deliver electrical therapy to a patient, the electrode assembly comprising an electrode electrically connectable to the control unit, the electrode comprising a sharp point at a distal end adapted to be inserted into the patient's tissue; and
a sharp point protection assembly operable with the electrode assembly for reducing risk of unintended exposure to the electrode's point.
US10/306,910 1999-12-01 2002-11-26 Percutaneous electrical therapy system with sharp point protection Abandoned US20040015206A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/451,547 US6539264B1 (en) 1999-12-01 1999-12-01 Percutaneous electrical therapy system with sharp point protection
US10/306,910 US20040015206A1 (en) 1999-12-01 2002-11-26 Percutaneous electrical therapy system with sharp point protection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/306,910 US20040015206A1 (en) 1999-12-01 2002-11-26 Percutaneous electrical therapy system with sharp point protection

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/451,547 Continuation US6539264B1 (en) 1999-12-01 1999-12-01 Percutaneous electrical therapy system with sharp point protection

Publications (1)

Publication Number Publication Date
US20040015206A1 true US20040015206A1 (en) 2004-01-22

Family

ID=23792670

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/451,547 Expired - Fee Related US6539264B1 (en) 1999-12-01 1999-12-01 Percutaneous electrical therapy system with sharp point protection
US10/306,910 Abandoned US20040015206A1 (en) 1999-12-01 2002-11-26 Percutaneous electrical therapy system with sharp point protection

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/451,547 Expired - Fee Related US6539264B1 (en) 1999-12-01 1999-12-01 Percutaneous electrical therapy system with sharp point protection

Country Status (1)

Country Link
US (2) US6539264B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8805519B2 (en) 2010-09-30 2014-08-12 Nevro Corporation Systems and methods for detecting intrathecal penetration
US8965482B2 (en) 2010-09-30 2015-02-24 Nevro Corporation Systems and methods for positioning implanted devices in a patient
US20160278677A1 (en) * 2013-11-12 2016-09-29 Cognoptix, Inc. Method for Measuring Fluorescence in Ocular Tissue

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6904324B2 (en) * 1999-12-01 2005-06-07 Meagan Medical, Inc. Method and apparatus for deploying a percutaneous probe
US6912424B2 (en) * 1999-12-01 2005-06-28 Meagan, Medical, Inc. Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient
AT5005U1 (en) * 2000-11-21 2002-02-25 Ernst Biegler Ges M B H Electrode system for electric punctual stimulation therapy and manipulation tool for this purpose
WO2003026735A2 (en) * 2001-09-28 2003-04-03 Meagan Medical, Inc. Method and apparatus for controlling percutaneous electrical signals
US20040015188A1 (en) * 2002-07-16 2004-01-22 Coulter George Gary Device for diminishing or eliminating the pain caused by a superficial therapeutic injection or superficial body tissue sampling
US7018384B2 (en) * 2002-08-29 2006-03-28 Medtronic, Inc. Medical passing device and method
US20050049663A1 (en) * 2003-08-29 2005-03-03 Harris Charmaine K. Percutaneous flat lead introducer
US8340779B2 (en) 2003-08-29 2012-12-25 Medtronic, Inc. Percutaneous flat lead introducer
US7228180B1 (en) 2003-10-09 2007-06-05 Stroke Play Ltd. Methods for treating victims of cerebrovascular disease
US20050149145A1 (en) * 2003-12-29 2005-07-07 Coulter George G. Enhanced device for diminishing or eliminating the pain caused by superficial therapeutic injection or superficial body tissue sampling or the pain from a superficial injury as well as for the reduction of hemorrhage from an injured area
EP1781180A2 (en) * 2004-07-08 2007-05-09 CliniWave, Inc. Rolling tube apparatus and method for treating a wound
US7792591B2 (en) * 2005-06-09 2010-09-07 Medtronic, Inc. Introducer for therapy delivery elements
US7797046B2 (en) 2006-10-11 2010-09-14 Cardiac Pacemakers, Inc. Percutaneous neurostimulator for modulating cardiovascular function
US7797041B2 (en) * 2006-10-11 2010-09-14 Cardiac Pacemakers, Inc. Transcutaneous neurostimulator for modulating cardiovascular function
US8433386B2 (en) * 2009-11-02 2013-04-30 Xialing Zhang Subdermal needle electrode cable assembly having movable needle safety cover integral therewith
US10130275B2 (en) 2013-06-13 2018-11-20 Dyansys, Inc. Method and apparatus for autonomic nervous system sensitivity-point testing
US10052257B2 (en) 2013-06-13 2018-08-21 Dyansys, Inc. Method and apparatus for stimulative electrotherapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861002A (en) * 1991-10-18 1999-01-19 Desai; Ashvin H. Endoscopic surgical instrument

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3090151A (en) 1958-02-14 1963-05-21 Stewart Trigg Underwater spear gun
US3030959A (en) 1959-09-04 1962-04-24 Praemeta Surgical lancet for blood sampling
US3208452A (en) 1960-09-08 1965-09-28 Panray Parlam Corp Surface treating device
US3943935A (en) 1973-09-07 1976-03-16 Cameron Robert C Disposable earlobe piercing apparatus
US3938526A (en) 1974-05-20 1976-02-17 Anderson Weston A Electrical acupuncture needle heater
US3983881A (en) 1975-05-21 1976-10-05 Telectronics Pty. Limited Muscle stimulator
DE2657053C3 (en) 1975-12-19 1980-01-31 Societe D'etudes Et D'applications Techniques S.E.D.A.T., Irigny, Rhone (Frankreich)
US4153059A (en) 1977-10-25 1979-05-08 Minnesota Mining And Manufacturing Company Urinary incontinence stimulator system
DE2800039C2 (en) 1978-01-02 1984-06-20 Horst Dr.Med. 6700 Ludwigshafen De Kief
US4207903A (en) 1978-04-28 1980-06-17 Medtronic, Inc. Device for screwing body tissue electrode into body tissue
US4256116A (en) 1978-07-03 1981-03-17 Technion Research And Development Foundation, Limited Transcutaneous pain reliever
US4431000A (en) 1978-11-29 1984-02-14 Gatron Corporation Transcutaneous nerve stimulator with pseusorandom pulse generator
US4281659A (en) 1979-03-12 1981-08-04 Roche Medical Electronics Inc. Applying and securing percutaneous or transcutaneous probes to the skin especially for fetal monitoring
US4284856A (en) 1979-09-24 1981-08-18 Hochmair Ingeborg Multi-frequency system and method for enhancing auditory stimulation and the like
FR2473882B1 (en) 1980-01-21 1983-10-28 Deloffre Auguste
US4381012A (en) 1980-09-24 1983-04-26 Wallant International Trade, Inc. Electrode placement device
FR2500309B3 (en) 1981-02-25 1983-02-11 Faiveley Sa
FR2500745B1 (en) 1981-03-02 1986-07-04 Dervieux Dominique An apparatus for sensing and pacing to the acupuncture treatment
US4437467A (en) 1981-12-11 1984-03-20 American Home Products Corporation Apparatus for monitoring fetal heartbeat and the like
US4512351A (en) 1982-11-19 1985-04-23 Cordis Corporation Percutaneous lead introducing system and method
CA1215128A (en) 1982-12-08 1986-12-09 Pedro Molina-Negro Electric nerve stimulator device
US4556064A (en) 1983-01-25 1985-12-03 Bruce Pomeranz Electrotherapy acupuncture apparatus and method
GB8406509D0 (en) 1984-03-13 1984-04-18 Bio Medical Res Ltd Electrical stimulation of muscle
US4583549A (en) 1984-05-30 1986-04-22 Samir Manoli ECG electrode pad
FR2567762B1 (en) 1984-07-20 1989-04-14 Simonin Philippe A device for cosmetic treatment of the skin
US4979508A (en) 1984-10-09 1990-12-25 Beck Stephen C Apparatus for generating phosphenes
DE3502913C1 (en) 1985-01-29 1986-07-03 Rau Guenter Sensors for non-invasive detection of electrophysiological Sizes
US4765310A (en) 1985-11-01 1988-08-23 Dynatens Research Corporation Electrical and magnetic pain treatment device
US4686996A (en) 1985-12-24 1987-08-18 Paul Ulbrich Electrode assembly for sensing heart activity
US5117826A (en) 1987-02-02 1992-06-02 Staodyn, Inc. Combined nerve fiber and body tissue stimulation apparatus and method
US4934371A (en) 1988-02-09 1990-06-19 American Home Products Corporation Fetal electrode product
US5012811A (en) 1988-02-09 1991-05-07 American Home Products Corporation Fetal electrode product with protective cap
US4895154A (en) 1988-02-19 1990-01-23 Staodynamics, Inc. Electronic stimulating device for enhanced healing of soft tissue wounds
US4949734A (en) 1988-08-25 1990-08-21 Gerald Bernstein Shield for electrosurgical device
US5094242A (en) 1988-11-07 1992-03-10 Regents Of The University Of California Implantable nerve stimulation device
US5211175A (en) 1988-11-07 1993-05-18 Regents Of The University Of California Method for implanting electra-acupuncture needle
GB8904998D0 (en) 1989-03-04 1989-04-19 Matthews Tony Anaesthetising apparatus
US4953564A (en) 1989-08-23 1990-09-04 Medtronic, Inc. Screw-in drug eluting lead
US5036850A (en) 1989-08-25 1991-08-06 Staodyn, Inc. Biphasic pulse output stage for electronic stimulating device
GB8924559D0 (en) 1989-11-01 1989-12-20 Capel Ifor D Method for transcranial electrotherapy
US5054486A (en) 1990-05-31 1991-10-08 Mamoru Yamada Remedial techniques for the treatment of painful disorders such as intervertebral disc hernia and the like
GB2255719A (en) 1991-05-11 1992-11-18 Tony Matthews Electro-therapy apparatus
US5851223A (en) 1991-05-21 1998-12-22 Medi Consultants, Inc. Combination non-intrusive analgesic neuroaugmentive system and method triple-modulated gigatens with optional bipolar spike
US5246014A (en) 1991-11-08 1993-09-21 Medtronic, Inc. Implantable lead system
US5255691A (en) 1991-11-13 1993-10-26 Medtronic, Inc. Percutaneous epidural lead introducing system and method
SE469465B (en) 1992-05-08 1993-07-12 Jens Schouenborg Medical device foer relief of smaerttillstaand comprising an electrode plate
US5281218A (en) * 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
DE4244690C2 (en) 1992-08-26 1995-03-16 Hewlett Packard Gmbh Inserter for a fetal scalp electrode
US5439440A (en) 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5810762A (en) 1995-04-10 1998-09-22 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
USD357069S (en) 1993-08-25 1995-04-04 Quinton Instrument Company Medical electrode
US5417719A (en) 1993-08-25 1995-05-23 Medtronic, Inc. Method of using a spinal cord stimulation lead
US5593429A (en) * 1994-06-28 1997-01-14 Cadwell Industries, Inc. Needle electrode with depth of penetration limiter
US5702359A (en) 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
AU6507096A (en) 1995-07-28 1997-02-26 Cardiotronics International, Inc. Disposable electro-dermal device
US5682233A (en) 1995-09-08 1997-10-28 Integ, Inc. Interstitial fluid sampler
US5649936A (en) 1995-09-19 1997-07-22 Real; Douglas D. Stereotactic guide apparatus for use with neurosurgical headframe
US5948008A (en) 1995-12-28 1999-09-07 S.L.T. Japan Co., Ltd. Apparatus for treatment of lumbar disc herniation
US6032064A (en) 1996-10-11 2000-02-29 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US5873849A (en) 1997-04-24 1999-02-23 Ichor Medical Systems, Inc. Electrodes and electrode arrays for generating electroporation inducing electrical fields
US5861015A (en) 1997-05-05 1999-01-19 Benja-Athon; Anuthep Modulation of the nervous system for treatment of pain and related disorders
US5968063A (en) 1997-05-14 1999-10-19 Jennifer Chu Intramuscular stimulation therapy facilitating device and method
US6050992A (en) * 1997-05-19 2000-04-18 Radiotherapeutics Corporation Apparatus and method for treating tissue with multiple electrodes
US5968011A (en) 1997-06-20 1999-10-19 Maersk Medical A/S Subcutaneous injection set
US6055453A (en) 1997-08-01 2000-04-25 Genetronics, Inc. Apparatus for addressing needle array electrodes for electroporation therapy
US5941845A (en) * 1997-08-05 1999-08-24 Irvine Biomedical, Inc. Catheter having multiple-needle electrode and methods thereof
US6009347A (en) 1998-01-27 1999-12-28 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6208893B1 (en) * 1998-01-27 2001-03-27 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6035236A (en) 1998-07-13 2000-03-07 Bionergy Therapeutics, Inc. Methods and apparatus for electrical microcurrent stimulation therapy
US6355021B1 (en) 1998-07-14 2002-03-12 Maersk Medical A/S Medical puncturing device
US6122547A (en) 1998-10-20 2000-09-19 Benja-Athon; Anuthep Consolidated electrical-lead acupuncture needle
US6269270B1 (en) 1998-10-26 2001-07-31 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator
US6304785B1 (en) 1998-10-27 2001-10-16 Huntington Medical Research Institute Electrode insertion tool
US6117077A (en) 1999-01-22 2000-09-12 Del Mar Medical Systems, Llc Long-term, ambulatory physiological recorder
US6341237B1 (en) 1999-10-25 2002-01-22 Arthur F. Hurtado Device for administrating electro-muscle stimulation and method of use
USD443063S1 (en) 2000-08-25 2001-05-29 Nexan Limited Chest multisensor array

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861002A (en) * 1991-10-18 1999-01-19 Desai; Ashvin H. Endoscopic surgical instrument

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8805519B2 (en) 2010-09-30 2014-08-12 Nevro Corporation Systems and methods for detecting intrathecal penetration
US8965482B2 (en) 2010-09-30 2015-02-24 Nevro Corporation Systems and methods for positioning implanted devices in a patient
US9345891B2 (en) 2010-09-30 2016-05-24 Nevro Corporation Systems and methods for positioning implanted devices in a patient
US9358388B2 (en) 2010-09-30 2016-06-07 Nevro Corporation Systems and methods for detecting intrathecal penetration
US10279183B2 (en) 2010-09-30 2019-05-07 Nevro Corp. Systems and methods for detecting intrathecal penetration
US20160278677A1 (en) * 2013-11-12 2016-09-29 Cognoptix, Inc. Method for Measuring Fluorescence in Ocular Tissue

Also Published As

Publication number Publication date
US6539264B1 (en) 2003-03-25

Similar Documents

Publication Publication Date Title
Hosobuchi et al. Chronic thalamic stimulation for the control of facial anesthesia dolorosa
EP2468355B1 (en) Apparatus for implanting an electrical stimulation system and a paddle style electrical stimulation lead
EP0013605B1 (en) Stylet insertion assembly for body implantable lead
EP0787505B1 (en) Active fixation medical electrical lead having improved turning tool
US5782892A (en) Medical lead adaptor for external medical device
US8086317B2 (en) System and method for electrical stimulation of the intervertebral disc
EP2370149B1 (en) Electrode design for leads of implantable electric stimulation systems and methods of making
US20080195034A1 (en) Instrument and method for delivery of anaesthetic drugs
EP1858583B1 (en) Pre-loaded lockable stimulating catheter for delivery of anaesthetic drugs
EP1075303B1 (en) Apparatus for expanding a stimulation lead body in situ
US20100274336A1 (en) Torque lock anchor and methods and devices using the anchor
US8996128B2 (en) Couplings for implanted leads and external stimulators, and associated systems and methods
US20080177351A1 (en) Method of providing percutaneous intramuscular stimulation
EP2142104B1 (en) Medical device implantation system
US7805197B2 (en) System and method using multiple timing channels for electrode adjustment during set up of an implanted stimulator device
US4569351A (en) Apparatus and method for stimulating micturition and certain muscles in paraplegic mammals
US20090157091A1 (en) Apparatus for Implanting Neural Stimulation Leads
US20080243220A1 (en) Lead anchor for implantable stimulation devices
US7798864B2 (en) Low-profile connector for a neurostimulation lead
EP1469911B1 (en) Neurostimulation lead stylet handle
US6904324B2 (en) Method and apparatus for deploying a percutaneous probe
US7460913B2 (en) Implantable electrode, insertion tool for use therewith, and insertion method
DE60017205T2 (en) A rechargeable device for spinal cord stimulation
AU2009288344B2 (en) Splittable catheter for neurostimulation lead
DE4335098B4 (en) Electrode feed line with holding element for a guide rod and its use

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEAGAN MEDICAL, INC., NEVADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VERTIS NEUROSCIENCE, INC.;REEL/FRAME:014090/0663

Effective date: 20030520

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION